Clinical Trial Update: Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma [Phase 1]

View source ↗

Summary

Phase I clinical trial update for ThINKK Adoptive Immunotherapy after allogeneic hematopoietic stem cell transplantation in children with acute lymphoblastic le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Neuroblastoma

Drugs mentioned

• ThINKK Adoptive Immunotherapy

Snippet

Sponsor: Michel Duval | Conditions: Leukaemia (Acute Lymphoblastic), Leukaemia (Acute Myeloid) | Phase 1 | Status: NOT_YET_RECRUITING